small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (288)
  • Capabilities (65)
  • Experience (138)
  • Insights & News (3,238)
  • Other Results (41)

Professionals 288 results

Michael Kimberly
Michael Kimberly
Partner
  • Washington, DC
Email
+1 202-282-5096
vCard

Partner

  • Washington, DC
Scott Glauberman
Scott Glauberman
Partner
  • Chicago
Email
+1 312-558-8103
vCard

Partner

  • Chicago
Linda Coberly
Linda Coberly
Partner
  • Chicago
Email
+1 312-558-8768
vCard

Partner

  • Chicago
View All Professionals

Capabilities 65 results

Practice Area

Appellate & Critical Motions

Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing....Read more

Practice Area

Litigation/Trials

Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial....Read more

Practice Area

Insurance Litigation

For decades, Winston has represented a broad array of clients in the insurance industry, including some of the world’s largest and best-known insurers. Our prowess in and understanding of the insurance industry encompasses not only its products, practices, and services, but also the increasing challenges posed by a world increasingly characterized by a fast-evolving technological landscape as well as financial, political, and environmental instability. Accordingly, Winston’s lawyers are among the most sought-after in the industry—not only by companies currently facing high-stakes litigations and investigations, but by those looking to take preventive action now in order to mitigate and manage their risk in the future....Read more

Experience 138 results

Experience

|

April 27, 2026

Winston Represents Initial Purchasers in GABX Leasing’s $1 Billion Inaugural Senior Notes Offering

Winston & Strawn LLP represented the initial purchasers, BofA Securities, Inc., MUFG Securities Americas Inc., SMBC Nikko Securities America, Inc., and Wells Fargo Securities, LLC, in connection with GABX Leasing LLC’s inaugural $1 billion Rule 144A offering of senior notes, with GATX Corporation as guarantor. The offering consisted of $500 million of 4.625% Senior Notes due 2031 and $500 million of 5.300% Senior Notes due 2036. GABX Leasing LLC is a joint venture between GATX Corporation and Brookfield Infrastructure Partners L.P. and its institutional partners, formed in connection with the approximately $4.2 billion acquisition of a portfolio of approximately 101,000 railcars from Wells Fargo. This financing represents a key component of the joint venture’s capital structure and supports the continued expansion of one of the largest railcar leasing platforms in North America. This transaction underscores Winston’s market leading capital markets practice and its continued role advising global financial institutions on complex, large scale financings, particularly those supporting critical infrastructure and transportation assets....Read more

Experience

|

April 6, 2026

MLBPI’s Licensing Fight Ends in Victory and Settlement with DraftKings

Winston is representing MLB Players Inc. (MLBPI), which serves as the exclusive group licensing representative for all MLB (major league baseball) players. MLBPI sued several online sportsbook and mobile-betting platforms, including DraftKings, over their use of hundreds of MLB player images and likenesses without MLBPI’s consent....Read more

Experience

|

April 2, 2026

Business Combination and Secured Financing of Keo World and Maha Capital AB

Served as legal counsel to KEO World, Inc., a Miami-based fintech platform specializing in embedded credit and B2B digital payments, in connection with its business combination with Maha Capital AB, a publicly listed investment company on Nasdaq Stockholm. The transaction, which closed on April 2, 2026, was structured as a reverse triangular merger through which KEO World became a wholly owned subsidiary of Maha, with KEO World's parent entity receiving approximately 141 million newly issued Maha shares and nearly 49.2 million earn-out warrants as consideration. In connection with the closing, Maha also executed two directed capital raises totaling USD 27 million at SEK 16 per share and announced a planned third raise of USD 8 million ahead of a contemplated dual listing on a U.S. national securities exchange. Based on publicly available disclosures, the combined transaction has been valued at approximately USD 680 million....Read more
View All Experience

Insights & News 3,238 results

Client Alert

|

April 30, 2026

|

4 Min Read

SEC and CFTC Propose Changes to Reduce Form PF Reporting Burdens

On April 20, 2026, the Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC) (collectively, the Commissions) jointly proposed amendments to Form PF (the Proposal) that, if adopted, would significantly reduce reporting burdens for private fund advisers. The Proposal would largely unwind the comprehensive amendments to Form PF adopted in February 2024 (the 2024 Amendments) before the October 1, 2026 compliance date, primarily by increasing filing thresholds and eliminating or streamlining a number of reporting requirements.

Capital Markets & Securities Law Watch

|

April 27, 2026

|

4 Min Read

SEC Grants Exemptive Relief for Shortened Equity Tender Offers

On April 16, 2026, the Securities and Exchange Commission’s (the SEC) Office of Mergers and Acquisitions in the Division of Corporation Finance (the Division) issued an exemptive order (the Order) permitting certain tender offers for equity securities to remain open for a minimum of 10 business days rather than the standard 20 business days, subject to strict conditions designed to preserve investor protections.

In the Media

|

April 24, 2026

|

1 Min Read

The American Lawyer Spotlights Winston’s Momentum with Six Partner Additions

Winston was featured in The American Lawyer following the firm’s addition of six lateral partners across Chicago, New York, Washington, D.C., and Dallas in April, further strengthening key practices including leveraged finance, investigations, intellectual property, and appellate litigation....Read more
View All Insights & News

Other Results 41 results

Site Content

What Is Epidemiology?

In the product liability context, epidemiology refers to the study of the incidence, distribution, and etiology of disease or harm in human populations. Epidemiological studies include a variety of different study designs, such as prospective and retrospective cohort studies, case-control studies, randomized controlled trials, and meta-analysis. Epidemiology is a critical, and sometimes mandatory, element for establishing general causation....Read more

Site Content

What Is General Causation?

In the product liability context, general causation is the legal and scientific determination of whether the product in question has the inherent capability to cause the alleged injury under certain circumstances. Establishment of general causation is a critical aspect of a plaintiff’s case, and typically requires scientific evidence, such as epidemiology or toxicology, and expert testimony to establish a causal connection between the product’s design, manufacturing, or warnings and the injury or injuries at issue. As contrasted to specific causation, the focus in a general causation inquiry is on whether the product or exposure, as a general matter, can cause the type of injury claimed by the plaintiff. A general causation inquiry does not assess any facts unique to a particular plaintiff....Read more

Europe

Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising